查看購物車
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
2026905

重症監護診斷市場預測至2034年－按產品類型、檢測類型、最終用戶和地區分類的全球分析

Critical Care Diagnostics Market Forecasts to 2034 - Global Analysis By Product (Cancer Markers Testing Kit, Fecal Occult Testing Kits, Cholesterol Test Strips and Other Products), Test Type, End User and By Geography
出版日期: | 出版商: Stratistics Market Research Consulting | 英文 | 商品交期: 2-3個工作天內

價格

根據 Stratistics MRC 的數據，預計到 2026 年，全球重症監護診斷市場規模將達到 15 億美元，並在預測期內以 5.5% 的複合年成長率成長，到 2034 年將達到 23 億美元。

重症監護診斷致力於對重症患者進行準確、快速的評估，這些患者需要即時接受治療。該領域涵蓋多種診斷程序和監測技術，旨在為醫療專業人員提供關鍵參數（例如器官功能、血液氣體和電解質）的最新數據。在這一領域，快速、準確的診斷設備在監測和評估重症患者發揮著至關重要的作用，能夠實現精準干預，並改善患者的整體預後。

根據美國醫學會（AMA）的數據，美國醫療保健支出為4.3兆美元，相當於人均1,2194美元。同年，醫療保健總支出約佔GDP的18.3%。

對診斷的認知提高

隨著全球醫療系統日益認知到在嚴重情況下快速介入的重要性，人們對先進的診斷工具和技術的興趣也日益濃厚。早期診斷能夠改善患者預後，並使醫護人員能夠及時採取有針對性的干涉措施，從而降低對醫療資源的整體需求。診斷技術的進步，尤其是更快、更準確的檢測方法的開發，也推動了這一趨勢。

發展中地區的進入限制

全球重症監護診斷市場面臨的主要障礙之一是開發中國家資源匱乏。這些地區常常面臨診斷資源不足、熟練人員短缺和醫療基礎設施落後等挑戰。因此，重症監護診斷的可近性和成本效益受到影響，阻礙了疾病的快速準確診斷。然而，要克服這些限制並改善開發中國家重症監護診斷的可及性，需要採取措施應對這些挑戰，包括增加對醫療基礎設施的投資以及實施有針對性的能力建設方案。

對即時檢測解決方案的需求日益成長

全球重症監護診斷市場對即時檢測 (POCT) 解決方案的需求日益成長，帶來了巨大的機會。在重症監護環境中，對快速、準確的診斷結果的需求日益迫切。 POCT 能夠幫助醫護人員及時做出患者照護決策。這一趨勢的驅動力在於，為了改善患者預後，需要加快並提高重症監護診斷的效率。此外，先進分子檢測和攜帶式診斷設備等最尖端科技的普及也推動了市場成長。隨著全球醫療系統將高效提供重症監護作為優先事項，對創新診斷解決方案的需求也不斷成長。

診斷技術的日益複雜化

尖端診斷技術的開發日益複雜且成本高昂，對全球重症監護診斷市場構成嚴重威脅。隨著對更精準、更先進的重症監護診斷的需求不斷成長，該行業面臨研發成本、監管和政策障礙以及對專業知識的需求等挑戰。此外，醫療報銷系統和政策環境的變化也可能影響市場擴張，給製造商帶來挑戰，並可能阻礙新型診斷技術的廣泛應用。

新冠疫情的影響：

新冠疫情導致診斷設備和儀器的需求激增。由於對快速準確檢測的需求，重症監護診斷技術不斷創新發展。分子診斷、影像解決方案和就地檢驗設備的研發投入也隨之增加。疫情凸顯了早期準確診斷在重症患者管理中的重要性，因此，重症監護診斷解決方案受到了更多關注。

在預測期內，妊娠和不孕症檢測套組細分市場預計將成為最大的細分市場。

妊娠和不孕症檢測套組市場預計將迎來快速成長。該市場專注於用於測量和追蹤與妊娠和不孕症相關參數的診斷設備。這些檢測套組對於早期發現懷孕和提高人們對不孕症的認知至關重要。這些檢測採用多種方法，包括血液和尿液分析，能夠提供準確的結果，從而幫助人們進行計劃生育和及時干預。此外，人們對生殖健康意識的提高以及自我監測趨勢的日益成長，也推動了對這些試劑盒的需求。

預計在預測期內，微生物學和傳染病檢查領域將呈現最高的複合年成長率。

微生物學和傳染病檢查領域預計將在識別和分析引起感染疾病的微生物病原體方面迎來蓬勃發展。這一重要領域可檢測多種檢體，包括血液、尿液和組織樣本，以檢測細菌、病毒、真菌和寄生蟲。聚合酵素鏈鎖反應(PCR) 和免疫檢測等先進診斷技術使醫護人員能夠快速且準確地診斷感染疾病。此外，分子技術和自動化技術的不斷進步也進一步提高了重症監護診斷中微生物學和傳染病檢查的效率和準確性。

市佔率最大的地區：

在北美，重症監護診斷市場正經歷顯著成長，這主要得益於慢性病盛行率的上升和醫療保健體系的先進化。呼吸系統疾病和心臟疾病的日益普遍推動了對重症監護診斷的需求成長。該地區對疾病早期檢測的重視以及高昂的醫療費用支出也是推動這一成長的重要因素。此外，政府主導的各項措施和宣傳宣傳活動，強調快速診斷和治療的重要性，也對北美市場產生了重大影響。

複合年成長率最高的地區：

在歐洲，由於人口老化以及重症監護環境中對快速、準確診斷檢測的需求等多種因素，市場正在不斷成長。為確保重症監護診斷設備的品質、安全性和有效性，相關監管措施已實施，促進了創新並推動了區域成長。嚴格的核准流程和高標準促使該產業企業加大研發投入。此外，歐洲也加強了與主要產業相關人員和學術機構的合作，並持續支持重症監護診斷的發展。

免費客製化服務：

所有購買此報告的客戶均可享受以下免費自訂選項之一：

  • 企業概況
    • 對其他市場參與者（最多 3 家公司）進行全面分析
    • 對主要公司進行SWOT分析（最多3家公司）
  • 區域分類
    • 應客戶要求，我們提供主要國家和地區的市場估算和預測，以及複合年成長率（註：需進行可行性檢查）。
  • 競爭性標竿分析
    • 根據產品系列、地理覆蓋範圍和策略聯盟對重點公司進行基準分析。

目錄

第1章執行摘要

第2章：引言

  • 概括
  • 相關利益者
  • 調查範圍
  • 調查方法
  • 研究材料

第3章 市場趨勢分析

  • 促進因素
  • 抑制因子
  • 機會
  • 威脅
  • 產品分析
  • 最終用戶分析
  • 新興市場
  • 新冠疫情的感染疾病

第4章：波特五力分析

  • 供應商的議價能力
  • 買方的議價能力
  • 替代品的威脅
  • 新進入者的威脅
  • 競爭公司之間的競爭

第5章 全球重症監護診斷市場：依產品分類

  • 癌症標記檢測套組
  • 大便潛血試驗試劑盒
  • 膽固醇試紙
  • 藥物濫用檢測套組
  • 妊娠及不孕症檢測套組
  • 心臟代謝監測套件
  • 傳染病檢查試劑盒
  • 血糖監測套件
  • 其他產品

第6章 全球重症監護診斷市場：依檢測類型分類

  • 流式細胞技術
  • 驗血
  • 血液凝固檢驗
  • 微生物學和傳染病檢查
  • 免疫蛋白
  • 一般化學測試和特殊化學測試
  • 其他測試類型

第7章 全球重症監護診斷市場：依最終使用者分類

  • 手術室
  • 加護病房
  • 急診室
  • 其他最終用戶

第8章 全球重症監護診斷市場：按地區分類

  • 北美洲
    • 美國
    • 加拿大
    • 墨西哥
  • 歐洲
    • 德國
    • 英國
    • 義大利
    • 法國
    • 西班牙
    • 其他歐洲國家
  • 亞太地區
    • 日本
    • 中國
    • 印度
    • 澳洲
    • 紐西蘭
    • 韓國
    • 其他亞太國家
  • 南美洲
    • 阿根廷
    • 巴西
    • 智利
    • 其他南美國家
  • 中東和非洲
    • 沙烏地阿拉伯
    • UAE
    • 卡達
    • 南非
    • 其他中東和非洲國家

第9章 主要發展

  • 合約、夥伴關係、合作關係、合資企業
  • 收購與併購
  • 新產品發布
  • 業務拓展
  • 其他關鍵策略

第10章：公司簡介

  • Abbott Laboratories
  • Alere, Inc.
  • Bayer Healthcare AG
  • Beckman Coulter, Inc.
  • Becton, Dickinson and Company
  • BioMerieux, Inc.
  • Bio-Rad Laboratories, Inc.
  • Biosensors Japan Co., Ltd.
  • Chembio Diagnostic Systems, Inc.
  • EKF Diagnostics Holdings PLC
  • Nanomix, Inc.
  • Nova Biomedical Corporation
  • Roche Diagnostics AG
  • Siemens Healthineers
  • Sysmex Corporation
Product Code: SMRC24722

According to Stratistics MRC, the Global Critical Care Diagnostics Market is accounted for $1.5 billion in 2026 and is expected to reach $2.3 billion by 2034 growing at a CAGR of 5.5% during the forecast period. Critical care diagnostics is devoted to assessing patients accurately and quickly who have life-threatening illnesses that frequently call for immediate treatment. This area of study includes a variety of diagnostic procedures and monitoring methods intended to give medical professionals access to up-to-date data on critical parameters like organ function, blood gases, and electrolytes. In this field, quick and accurate diagnostic instruments play a major role in monitoring and assessing critically ill patients, enabling focused interventions, and enhancing overall patient outcomes.

According to America Medical Association, the U.S. spent USD 4.3 trillion on healthcare, which equates to USD 12,194 per capita. The overall health spending was around 18.3% of the GDP in the same year.

Market Dynamics:

Driver:

Increased awareness on diagnosis

An increasing focus is being placed on advanced diagnostic tools and technologies as healthcare systems across the globe acknowledge the significance of prompt intervention in critical conditions. Early diagnosis improves patient outcomes and lessens the overall demand on healthcare resources by allowing medical professionals to launch focused, timely interventions. Improvements in diagnostic techniques are also driving this trend, resulting in the creation of testing methods that are faster and more accurate.

Restraint:

Limited accessibility in developing regions

A major barrier to the global critical care diagnostics market is the lack of accessibility in developing nations. These areas frequently struggle with issues like a lack of resources for diagnostic facilities, a shortage of skilled workers, and inadequate healthcare infrastructure. Consequently, there are compromises in the accessibility and cost-effectiveness of critical care diagnostics, impeding prompt and precise disease diagnosis. However, to get around this restriction and enhance the accessibility of critical care diagnostics in developing nations, efforts must be made to address these issues, such as through increased investment in healthcare infrastructure and focused capacity-building programs.

Opportunity:

Growing demand for POCT solutions

The increasing need for point-of-care testing (POCT) solutions presents a major opportunity in the global critical care diagnostics market. In critical care settings, there is a growing focus on quick and accurate diagnostic results. POCT helps medical professionals make timely decisions about patient care. In order to improve patient outcomes, this trend is motivated by the need to expedite critical care diagnostics and increase their efficiency. The market's growth is also aided by the uptake of cutting-edge technologies like sophisticated molecular testing and portable diagnostic devices. Innovative diagnostic solutions are in high demand as global healthcare systems prioritize providing critical care efficiently.

Threat:

Increasing complexity associated with diagnostic technologies

The growing complexity and expense of creating cutting-edge diagnostic technologies pose a serious threat to the global critical care diagnostics market. The industry faces difficulties with regard to costs associated with research and development, obstacles posed by regulations, and the requirement for specialized knowledge as the demand for more accurate and sophisticated critical care diagnostics increases. However, changing healthcare reimbursement and policy landscapes may have an effect on market expansion, posing challenges for manufacturers and impeding the uptake of novel diagnostic technologies.

Covid-19 Impact:

The COVID-19 pandemic has caused a sharp increase in demand for diagnostic instruments and equipment. Critical care diagnostics technology has advanced due to innovation and advancements driven by the need for fast and accurate testing. Research and development expenditures for molecular diagnostics, imaging solutions, and point-of-care testing devices have increased. A greater emphasis on critical care diagnostic solutions has resulted from the pandemic's emphasis on the significance of early and accurate diagnostics in the management of critically ill patients.

The pregnancy and fertility testing kits segment is expected to be the largest during the forecast period

The pregnancy and fertility testing kits segment is estimated to grow at a rapid pace. The pregnancy and fertility testing kits segment focuses on diagnostic instruments made to measure and track parameters related to pregnancy and fertility. These kits are essential for early pregnancy detection and for educating people about their fertility. These tests, which use different techniques like blood or urine analysis, yield precise results that allow for family planning and prompt intervention. Additionally, the demand for these kits has been driven by the rising trend of self-monitoring along with increased awareness of reproductive health.

The microbiology and infectious test segment is expected to have the highest CAGR during the forecast period

The microbiology and infectious test segment is expected to hold lucrative growth as it identifies and analyzes microbial pathogens responsible for infectious diseases. This crucial segment involves the examination of various specimens, such as blood, urine, and tissue samples, to detect bacteria, viruses, fungi, and parasites. Utilizing advanced diagnostic technologies like polymerase chain reaction (PCR) and immunoassays, healthcare professionals can rapidly and accurately diagnose infectious conditions. Additionally, the ongoing advancements in molecular techniques and automation further enhance the efficiency and precision of microbiological and infectious tests in critical care diagnostics.

Region with largest share:

The market for critical care diagnostics has grown substantially in the North American region as a result of rising rates of chronic illness and sophisticated healthcare systems. The need for critical care diagnostics has increased due to the growing prevalence of illnesses like respiratory and cardiac disorders. The growth of critical care diagnostics has been facilitated by the region's emphasis on early disease detection and high healthcare spending. Moreover, North America has also been deeply influenced by government initiatives and awareness campaigns that highlight the significance of prompt diagnosis and treatment.

Region with highest CAGR:

The European region has experienced growth in the market as a result of various factors, including population aging, need for quick and precise diagnostic testing in critical care settings. Regulatory measures have been implemented to ensure the quality, safety, and efficacy of critical care diagnostic devices, fostering innovation and driving regional growth. Stringent approval processes and adherence to high-quality standards have led to increased investment in research and development by companies in the sector. In addition, partnerships between major industry participants and academic institutions and support for critical care diagnostics continued in Europe.

Key players in the market

Some of the key players in Critical Care Diagnostics market include Abbott Laboratories, Alere, Inc., Bayer Healthcare AG, Beckman Coulter, Inc., Becton, Dickinson and Company, BioMerieux, Inc., Bio-Rad Laboratories, Inc., Biosensors Japan Co., Ltd., Chembio Diagnostic Systems, Inc., EKF Diagnostics Holdings PLC, Nanomix, Inc., Nova Biomedical Corporation, Roche Diagnostics AG, Siemens Healthineers and Sysmex Corporation.

Key Developments:

In December 2023, Fujirebio Holdings, Inc. and Sysmex Corporation announced that they have signed an agreement for the mutual supply of reagent raw materials owned by both companies. The Agreement is based on a basic agreement on business collaboration in the field of immunoassay*1 which the two companies signed.

In March 2023, ABEC announced it will provide customized, large-scale bioprocess equipment, including a 14,500-liter total volume stainless steel fermenter and an 8,000 liter media preparation system to EKF Life Sciences, a division of EKF Diagnostics Holdings plc. The agreement provides EKF Life Sciences' South Bend, Indiana facility with the bioprocess equipment which will significantly expand EKF's production capacity of enzymes used in a variety of diagnostic and Life Science applications.

Products Covered:

  • Cancer Markers Testing Kit
  • Fecal Occult Testing Kits
  • Cholesterol Test Strips
  • Drugs Of Abuse Testing Kits
  • Pregnancy and Fertility Testing Kits
  • Cardiometabolic Monitoring Kits
  • Infectious Disease Testing Kits
  • Glucose Monitoring Kits
  • Other Products

Test Types Covered:

  • Flow Cytometry
  • Hematology Test
  • Coagulation Test
  • Microbiology and Infectious Test
  • Immunoprotein
  • Routine and Special Chemistry
  • Other Test Types

End Users Covered:

  • Operating Room
  • Intensive Care Unit
  • Emergency Room
  • Other End Users

Regions Covered:

  • North America
    • US
    • Canada
    • Mexico
  • Europe
    • Germany
    • UK
    • Italy
    • France
    • Spain
    • Rest of Europe
  • Asia Pacific
    • Japan
    • China
    • India
    • Australia
    • New Zealand
    • South Korea
    • Rest of Asia Pacific
  • South America
    • Argentina
    • Brazil
    • Chile
    • Rest of South America
  • Middle East & Africa
    • Saudi Arabia
    • UAE
    • Qatar
    • South Africa
    • Rest of Middle East & Africa

What our report offers:

  • Market share assessments for the regional and country-level segments
  • Strategic recommendations for the new entrants
  • Covers Market data for the years 2023, 2024, 2025, 2026, 2027, 2028, 2030, 2032 and 2034
  • Market Trends (Drivers, Constraints, Opportunities, Threats, Challenges, Investment Opportunities, and recommendations)
  • Strategic recommendations in key business segments based on the market estimations
  • Competitive landscaping mapping the key common trends
  • Company profiling with detailed strategies, financials, and recent developments
  • Supply chain trends mapping the latest technological advancements

Free Customization Offerings:

All the customers of this report will be entitled to receive one of the following free customization options:

  • Company Profiling
    • Comprehensive profiling of additional market players (up to 3)
    • SWOT Analysis of key players (up to 3)
  • Regional Segmentation
    • Market estimations, Forecasts and CAGR of any prominent country as per the client's interest (Note: Depends on feasibility check)
  • Competitive Benchmarking
    • Benchmarking of key players based on product portfolio, geographical presence, and strategic alliances

Table of Contents

1 Executive Summary

2 Preface

  • 2.1 Abstract
  • 2.2 Stake Holders
  • 2.3 Research Scope
  • 2.4 Research Methodology
    • 2.4.1 Data Mining
    • 2.4.2 Data Analysis
    • 2.4.3 Data Validation
    • 2.4.4 Research Approach
  • 2.5 Research Sources
    • 2.5.1 Primary Research Sources
    • 2.5.2 Secondary Research Sources
    • 2.5.3 Assumptions

3 Market Trend Analysis

  • 3.1 Introduction
  • 3.2 Drivers
  • 3.3 Restraints
  • 3.4 Opportunities
  • 3.5 Threats
  • 3.6 Product Analysis
  • 3.7 End User Analysis
  • 3.8 Emerging Markets
  • 3.9 Impact of Covid-19

4 Porters Five Force Analysis

  • 4.1 Bargaining power of suppliers
  • 4.2 Bargaining power of buyers
  • 4.3 Threat of substitutes
  • 4.4 Threat of new entrants
  • 4.5 Competitive rivalry

5 Global Critical Care Diagnostics Market, By Product

  • 5.1 Introduction
  • 5.2 Cancer Markers Testing Kit
  • 5.3 Fecal Occult Testing Kits
  • 5.4 Cholesterol Test Strips
  • 5.5 Drugs Of Abuse Testing Kits
  • 5.6 Pregnancy and Fertility Testing Kits
  • 5.7 Cardiometabolic Monitoring Kits
  • 5.8 Infectious Disease Testing Kits
  • 5.9 Glucose Monitoring Kits
  • 5.10 Other Products

6 Global Critical Care Diagnostics Market, By Test Type

  • 6.1 Introduction
  • 6.2 Flow Cytometry
  • 6.3 Hematology Test
  • 6.4 Coagulation Test
  • 6.5 Microbiology and Infectious Test
  • 6.6 Immunoprotein
  • 6.7 Routine and Special Chemistry
  • 6.8 Other Test Types

7 Global Critical Care Diagnostics Market, By End User

  • 7.1 Introduction
  • 7.2 Operating Room
  • 7.3 Intensive Care Unit
  • 7.4 Emergency Room
  • 7.5 Other End Users

8 Global Critical Care Diagnostics Market, By Geography

  • 8.1 Introduction
  • 8.2 North America
    • 8.2.1 US
    • 8.2.2 Canada
    • 8.2.3 Mexico
  • 8.3 Europe
    • 8.3.1 Germany
    • 8.3.2 UK
    • 8.3.3 Italy
    • 8.3.4 France
    • 8.3.5 Spain
    • 8.3.6 Rest of Europe
  • 8.4 Asia Pacific
    • 8.4.1 Japan
    • 8.4.2 China
    • 8.4.3 India
    • 8.4.4 Australia
    • 8.4.5 New Zealand
    • 8.4.6 South Korea
    • 8.4.7 Rest of Asia Pacific
  • 8.5 South America
    • 8.5.1 Argentina
    • 8.5.2 Brazil
    • 8.5.3 Chile
    • 8.5.4 Rest of South America
  • 8.6 Middle East & Africa
    • 8.6.1 Saudi Arabia
    • 8.6.2 UAE
    • 8.6.3 Qatar
    • 8.6.4 South Africa
    • 8.6.5 Rest of Middle East & Africa

9 Key Developments

  • 9.1 Agreements, Partnerships, Collaborations and Joint Ventures
  • 9.2 Acquisitions & Mergers
  • 9.3 New Product Launch
  • 9.4 Expansions
  • 9.5 Other Key Strategies

10 Company Profiling

  • 10.1 Abbott Laboratories
  • 10.2 Alere, Inc.
  • 10.3 Bayer Healthcare AG
  • 10.4 Beckman Coulter, Inc.
  • 10.5 Becton, Dickinson and Company
  • 10.6 BioMerieux, Inc.
  • 10.7 Bio-Rad Laboratories, Inc.
  • 10.8 Biosensors Japan Co., Ltd.
  • 10.9 Chembio Diagnostic Systems, Inc.
  • 10.10 EKF Diagnostics Holdings PLC
  • 10.11 Nanomix, Inc.
  • 10.12 Nova Biomedical Corporation
  • 10.13 Roche Diagnostics AG
  • 10.14 Siemens Healthineers
  • 10.15 Sysmex Corporation

List of Tables

  • Table 1 Global Critical Care Diagnostics Market Outlook, By Region (2023-2034) ($MN)
  • Table 2 Global Critical Care Diagnostics Market Outlook, By Product (2023-2034) ($MN)
  • Table 3 Global Critical Care Diagnostics Market Outlook, By Cancer Markers Testing Kit (2023-2034) ($MN)
  • Table 4 Global Critical Care Diagnostics Market Outlook, By Fecal Occult Testing Kits (2023-2034) ($MN)
  • Table 5 Global Critical Care Diagnostics Market Outlook, By Cholesterol Test Strips (2023-2034) ($MN)
  • Table 6 Global Critical Care Diagnostics Market Outlook, By Drugs Of Abuse Testing Kits (2023-2034) ($MN)
  • Table 7 Global Critical Care Diagnostics Market Outlook, By Pregnancy and Fertility Testing Kits (2023-2034) ($MN)
  • Table 8 Global Critical Care Diagnostics Market Outlook, By Cardiometabolic Monitoring Kits (2023-2034) ($MN)
  • Table 9 Global Critical Care Diagnostics Market Outlook, By Infectious Disease Testing Kits (2023-2034) ($MN)
  • Table 10 Global Critical Care Diagnostics Market Outlook, By Glucose Monitoring Kits (2023-2034) ($MN)
  • Table 11 Global Critical Care Diagnostics Market Outlook, By Other Products (2023-2034) ($MN)
  • Table 12 Global Critical Care Diagnostics Market Outlook, By Test Type (2023-2034) ($MN)
  • Table 13 Global Critical Care Diagnostics Market Outlook, By Flow Cytometry (2023-2034) ($MN)
  • Table 14 Global Critical Care Diagnostics Market Outlook, By Hematology Test (2023-2034) ($MN)
  • Table 15 Global Critical Care Diagnostics Market Outlook, By Coagulation Test (2023-2034) ($MN)
  • Table 16 Global Critical Care Diagnostics Market Outlook, By Microbiology and Infectious Test (2023-2034) ($MN)
  • Table 17 Global Critical Care Diagnostics Market Outlook, By Immunoprotein (2023-2034) ($MN)
  • Table 18 Global Critical Care Diagnostics Market Outlook, By Routine and Special Chemistry (2023-2034) ($MN)
  • Table 19 Global Critical Care Diagnostics Market Outlook, By Other Test Types (2023-2034) ($MN)
  • Table 20 Global Critical Care Diagnostics Market Outlook, By End User (2023-2034) ($MN)
  • Table 21 Global Critical Care Diagnostics Market Outlook, By Operating Room (2023-2034) ($MN)
  • Table 22 Global Critical Care Diagnostics Market Outlook, By Intensive Care Unit (2023-2034) ($MN)
  • Table 23 Global Critical Care Diagnostics Market Outlook, By Emergency Room (2023-2034) ($MN)
  • Table 24 Global Critical Care Diagnostics Market Outlook, By Other End Users (2023-2034) ($MN)
  • Table 25 North America Critical Care Diagnostics Market Outlook, By Country (2023-2034) ($MN)
  • Table 26 North America Critical Care Diagnostics Market Outlook, By Product (2023-2034) ($MN)
  • Table 27 North America Critical Care Diagnostics Market Outlook, By Cancer Markers Testing Kit (2023-2034) ($MN)
  • Table 28 North America Critical Care Diagnostics Market Outlook, By Fecal Occult Testing Kits (2023-2034) ($MN)
  • Table 29 North America Critical Care Diagnostics Market Outlook, By Cholesterol Test Strips (2023-2034) ($MN)
  • Table 30 North America Critical Care Diagnostics Market Outlook, By Drugs Of Abuse Testing Kits (2023-2034) ($MN)
  • Table 31 North America Critical Care Diagnostics Market Outlook, By Pregnancy and Fertility Testing Kits (2023-2034) ($MN)
  • Table 32 North America Critical Care Diagnostics Market Outlook, By Cardiometabolic Monitoring Kits (2023-2034) ($MN)
  • Table 33 North America Critical Care Diagnostics Market Outlook, By Infectious Disease Testing Kits (2023-2034) ($MN)
  • Table 34 North America Critical Care Diagnostics Market Outlook, By Glucose Monitoring Kits (2023-2034) ($MN)
  • Table 35 North America Critical Care Diagnostics Market Outlook, By Other Products (2023-2034) ($MN)
  • Table 36 North America Critical Care Diagnostics Market Outlook, By Test Type (2023-2034) ($MN)
  • Table 37 North America Critical Care Diagnostics Market Outlook, By Flow Cytometry (2023-2034) ($MN)
  • Table 38 North America Critical Care Diagnostics Market Outlook, By Hematology Test (2023-2034) ($MN)
  • Table 39 North America Critical Care Diagnostics Market Outlook, By Coagulation Test (2023-2034) ($MN)
  • Table 40 North America Critical Care Diagnostics Market Outlook, By Microbiology and Infectious Test (2023-2034) ($MN)
  • Table 41 North America Critical Care Diagnostics Market Outlook, By Immunoprotein (2023-2034) ($MN)
  • Table 42 North America Critical Care Diagnostics Market Outlook, By Routine and Special Chemistry (2023-2034) ($MN)
  • Table 43 North America Critical Care Diagnostics Market Outlook, By Other Test Types (2023-2034) ($MN)
  • Table 44 North America Critical Care Diagnostics Market Outlook, By End User (2023-2034) ($MN)
  • Table 45 North America Critical Care Diagnostics Market Outlook, By Operating Room (2023-2034) ($MN)
  • Table 46 North America Critical Care Diagnostics Market Outlook, By Intensive Care Unit (2023-2034) ($MN)
  • Table 47 North America Critical Care Diagnostics Market Outlook, By Emergency Room (2023-2034) ($MN)
  • Table 48 North America Critical Care Diagnostics Market Outlook, By Other End Users (2023-2034) ($MN)
  • Table 49 Europe Critical Care Diagnostics Market Outlook, By Country (2023-2034) ($MN)
  • Table 50 Europe Critical Care Diagnostics Market Outlook, By Product (2023-2034) ($MN)
  • Table 51 Europe Critical Care Diagnostics Market Outlook, By Cancer Markers Testing Kit (2023-2034) ($MN)
  • Table 52 Europe Critical Care Diagnostics Market Outlook, By Fecal Occult Testing Kits (2023-2034) ($MN)
  • Table 53 Europe Critical Care Diagnostics Market Outlook, By Cholesterol Test Strips (2023-2034) ($MN)
  • Table 54 Europe Critical Care Diagnostics Market Outlook, By Drugs Of Abuse Testing Kits (2023-2034) ($MN)
  • Table 55 Europe Critical Care Diagnostics Market Outlook, By Pregnancy and Fertility Testing Kits (2023-2034) ($MN)
  • Table 56 Europe Critical Care Diagnostics Market Outlook, By Cardiometabolic Monitoring Kits (2023-2034) ($MN)
  • Table 57 Europe Critical Care Diagnostics Market Outlook, By Infectious Disease Testing Kits (2023-2034) ($MN)
  • Table 58 Europe Critical Care Diagnostics Market Outlook, By Glucose Monitoring Kits (2023-2034) ($MN)
  • Table 59 Europe Critical Care Diagnostics Market Outlook, By Other Products (2023-2034) ($MN)
  • Table 60 Europe Critical Care Diagnostics Market Outlook, By Test Type (2023-2034) ($MN)
  • Table 61 Europe Critical Care Diagnostics Market Outlook, By Flow Cytometry (2023-2034) ($MN)
  • Table 62 Europe Critical Care Diagnostics Market Outlook, By Hematology Test (2023-2034) ($MN)
  • Table 63 Europe Critical Care Diagnostics Market Outlook, By Coagulation Test (2023-2034) ($MN)
  • Table 64 Europe Critical Care Diagnostics Market Outlook, By Microbiology and Infectious Test (2023-2034) ($MN)
  • Table 65 Europe Critical Care Diagnostics Market Outlook, By Immunoprotein (2023-2034) ($MN)
  • Table 66 Europe Critical Care Diagnostics Market Outlook, By Routine and Special Chemistry (2023-2034) ($MN)
  • Table 67 Europe Critical Care Diagnostics Market Outlook, By Other Test Types (2023-2034) ($MN)
  • Table 68 Europe Critical Care Diagnostics Market Outlook, By End User (2023-2034) ($MN)
  • Table 69 Europe Critical Care Diagnostics Market Outlook, By Operating Room (2023-2034) ($MN)
  • Table 70 Europe Critical Care Diagnostics Market Outlook, By Intensive Care Unit (2023-2034) ($MN)
  • Table 71 Europe Critical Care Diagnostics Market Outlook, By Emergency Room (2023-2034) ($MN)
  • Table 72 Europe Critical Care Diagnostics Market Outlook, By Other End Users (2023-2034) ($MN)
  • Table 73 Asia Pacific Critical Care Diagnostics Market Outlook, By Country (2023-2034) ($MN)
  • Table 74 Asia Pacific Critical Care Diagnostics Market Outlook, By Product (2023-2034) ($MN)
  • Table 75 Asia Pacific Critical Care Diagnostics Market Outlook, By Cancer Markers Testing Kit (2023-2034) ($MN)
  • Table 76 Asia Pacific Critical Care Diagnostics Market Outlook, By Fecal Occult Testing Kits (2023-2034) ($MN)
  • Table 77 Asia Pacific Critical Care Diagnostics Market Outlook, By Cholesterol Test Strips (2023-2034) ($MN)
  • Table 78 Asia Pacific Critical Care Diagnostics Market Outlook, By Drugs Of Abuse Testing Kits (2023-2034) ($MN)
  • Table 79 Asia Pacific Critical Care Diagnostics Market Outlook, By Pregnancy and Fertility Testing Kits (2023-2034) ($MN)
  • Table 80 Asia Pacific Critical Care Diagnostics Market Outlook, By Cardiometabolic Monitoring Kits (2023-2034) ($MN)
  • Table 81 Asia Pacific Critical Care Diagnostics Market Outlook, By Infectious Disease Testing Kits (2023-2034) ($MN)
  • Table 82 Asia Pacific Critical Care Diagnostics Market Outlook, By Glucose Monitoring Kits (2023-2034) ($MN)
  • Table 83 Asia Pacific Critical Care Diagnostics Market Outlook, By Other Products (2023-2034) ($MN)
  • Table 84 Asia Pacific Critical Care Diagnostics Market Outlook, By Test Type (2023-2034) ($MN)
  • Table 85 Asia Pacific Critical Care Diagnostics Market Outlook, By Flow Cytometry (2023-2034) ($MN)
  • Table 86 Asia Pacific Critical Care Diagnostics Market Outlook, By Hematology Test (2023-2034) ($MN)
  • Table 87 Asia Pacific Critical Care Diagnostics Market Outlook, By Coagulation Test (2023-2034) ($MN)
  • Table 88 Asia Pacific Critical Care Diagnostics Market Outlook, By Microbiology and Infectious Test (2023-2034) ($MN)
  • Table 89 Asia Pacific Critical Care Diagnostics Market Outlook, By Immunoprotein (2023-2034) ($MN)
  • Table 90 Asia Pacific Critical Care Diagnostics Market Outlook, By Routine and Special Chemistry (2023-2034) ($MN)
  • Table 91 Asia Pacific Critical Care Diagnostics Market Outlook, By Other Test Types (2023-2034) ($MN)
  • Table 92 Asia Pacific Critical Care Diagnostics Market Outlook, By End User (2023-2034) ($MN)
  • Table 93 Asia Pacific Critical Care Diagnostics Market Outlook, By Operating Room (2023-2034) ($MN)
  • Table 94 Asia Pacific Critical Care Diagnostics Market Outlook, By Intensive Care Unit (2023-2034) ($MN)
  • Table 95 Asia Pacific Critical Care Diagnostics Market Outlook, By Emergency Room (2023-2034) ($MN)
  • Table 96 Asia Pacific Critical Care Diagnostics Market Outlook, By Other End Users (2023-2034) ($MN)
  • Table 97 South America Critical Care Diagnostics Market Outlook, By Country (2023-2034) ($MN)
  • Table 98 South America Critical Care Diagnostics Market Outlook, By Product (2023-2034) ($MN)
  • Table 99 South America Critical Care Diagnostics Market Outlook, By Cancer Markers Testing Kit (2023-2034) ($MN)
  • Table 100 South America Critical Care Diagnostics Market Outlook, By Fecal Occult Testing Kits (2023-2034) ($MN)
  • Table 101 South America Critical Care Diagnostics Market Outlook, By Cholesterol Test Strips (2023-2034) ($MN)
  • Table 102 South America Critical Care Diagnostics Market Outlook, By Drugs Of Abuse Testing Kits (2023-2034) ($MN)
  • Table 103 South America Critical Care Diagnostics Market Outlook, By Pregnancy and Fertility Testing Kits (2023-2034) ($MN)
  • Table 104 South America Critical Care Diagnostics Market Outlook, By Cardiometabolic Monitoring Kits (2023-2034) ($MN)
  • Table 105 South America Critical Care Diagnostics Market Outlook, By Infectious Disease Testing Kits (2023-2034) ($MN)
  • Table 106 South America Critical Care Diagnostics Market Outlook, By Glucose Monitoring Kits (2023-2034) ($MN)
  • Table 107 South America Critical Care Diagnostics Market Outlook, By Other Products (2023-2034) ($MN)
  • Table 108 South America Critical Care Diagnostics Market Outlook, By Test Type (2023-2034) ($MN)
  • Table 109 South America Critical Care Diagnostics Market Outlook, By Flow Cytometry (2023-2034) ($MN)
  • Table 110 South America Critical Care Diagnostics Market Outlook, By Hematology Test (2023-2034) ($MN)
  • Table 111 South America Critical Care Diagnostics Market Outlook, By Coagulation Test (2023-2034) ($MN)
  • Table 112 South America Critical Care Diagnostics Market Outlook, By Microbiology and Infectious Test (2023-2034) ($MN)
  • Table 113 South America Critical Care Diagnostics Market Outlook, By Immunoprotein (2023-2034) ($MN)
  • Table 114 South America Critical Care Diagnostics Market Outlook, By Routine and Special Chemistry (2023-2034) ($MN)
  • Table 115 South America Critical Care Diagnostics Market Outlook, By Other Test Types (2023-2034) ($MN)
  • Table 116 South America Critical Care Diagnostics Market Outlook, By End User (2023-2034) ($MN)
  • Table 117 South America Critical Care Diagnostics Market Outlook, By Operating Room (2023-2034) ($MN)
  • Table 118 South America Critical Care Diagnostics Market Outlook, By Intensive Care Unit (2023-2034) ($MN)
  • Table 119 South America Critical Care Diagnostics Market Outlook, By Emergency Room (2023-2034) ($MN)
  • Table 120 South America Critical Care Diagnostics Market Outlook, By Other End Users (2023-2034) ($MN)
  • Table 121 Middle East & Africa Critical Care Diagnostics Market Outlook, By Country (2023-2034) ($MN)
  • Table 122 Middle East & Africa Critical Care Diagnostics Market Outlook, By Product (2023-2034) ($MN)
  • Table 123 Middle East & Africa Critical Care Diagnostics Market Outlook, By Cancer Markers Testing Kit (2023-2034) ($MN)
  • Table 124 Middle East & Africa Critical Care Diagnostics Market Outlook, By Fecal Occult Testing Kits (2023-2034) ($MN)
  • Table 125 Middle East & Africa Critical Care Diagnostics Market Outlook, By Cholesterol Test Strips (2023-2034) ($MN)
  • Table 126 Middle East & Africa Critical Care Diagnostics Market Outlook, By Drugs Of Abuse Testing Kits (2023-2034) ($MN)
  • Table 127 Middle East & Africa Critical Care Diagnostics Market Outlook, By Pregnancy and Fertility Testing Kits (2023-2034) ($MN)
  • Table 128 Middle East & Africa Critical Care Diagnostics Market Outlook, By Cardiometabolic Monitoring Kits (2023-2034) ($MN)
  • Table 129 Middle East & Africa Critical Care Diagnostics Market Outlook, By Infectious Disease Testing Kits (2023-2034) ($MN)
  • Table 130 Middle East & Africa Critical Care Diagnostics Market Outlook, By Glucose Monitoring Kits (2023-2034) ($MN)
  • Table 131 Middle East & Africa Critical Care Diagnostics Market Outlook, By Other Products (2023-2034) ($MN)
  • Table 132 Middle East & Africa Critical Care Diagnostics Market Outlook, By Test Type (2023-2034) ($MN)
  • Table 133 Middle East & Africa Critical Care Diagnostics Market Outlook, By Flow Cytometry (2023-2034) ($MN)
  • Table 134 Middle East & Africa Critical Care Diagnostics Market Outlook, By Hematology Test (2023-2034) ($MN)
  • Table 135 Middle East & Africa Critical Care Diagnostics Market Outlook, By Coagulation Test (2023-2034) ($MN)
  • Table 136 Middle East & Africa Critical Care Diagnostics Market Outlook, By Microbiology and Infectious Test (2023-2034) ($MN)
  • Table 137 Middle East & Africa Critical Care Diagnostics Market Outlook, By Immunoprotein (2023-2034) ($MN)
  • Table 138 Middle East & Africa Critical Care Diagnostics Market Outlook, By Routine and Special Chemistry (2023-2034) ($MN)
  • Table 139 Middle East & Africa Critical Care Diagnostics Market Outlook, By Other Test Types (2023-2034) ($MN)
  • Table 140 Middle East & Africa Critical Care Diagnostics Market Outlook, By End User (2023-2034) ($MN)
  • Table 141 Middle East & Africa Critical Care Diagnostics Market Outlook, By Operating Room (2023-2034) ($MN)
  • Table 142 Middle East & Africa Critical Care Diagnostics Market Outlook, By Intensive Care Unit (2023-2034) ($MN)
  • Table 143 Middle East & Africa Critical Care Diagnostics Market Outlook, By Emergency Room (2023-2034) ($MN)
  • Table 144 Middle East & Africa Critical Care Diagnostics Market Outlook, By Other End Users (2023-2034) ($MN)